NEW YORK (GenomeWeb) – Canon BioMedical announced today it is has signed an exclusive deal with Molecular Biology Systems to market and sell the Dutch firm's NextGenPCR thermal cycler instrument and consumables in the US and Canada.
Canon will initially distribute the NextGenPCR instrument in the US and will introduce it at upcoming conferences, the firm said in a statement.
The NextGenPCR thermal cycler enables two-minute, 30-cycle amplification of 100 base pair fragments. Consumables for the instrument include 96- and 384-well microplates that are sealed with polypropylene foil with wells holding between five and 20 microliters, as well as proprietary foil-piercing pipette tips to recover PCR products from the sealed microplates.
"Researchers want answers as fast as possible and offering the NextGenPCR products to our customers will shorten their protocols without requiring them to change their procedures," said Dennis Snyder, Canon BioMedical's senior director of global commercial operations.
MBS recently signed distribution agreements in other countries including with PreMed Lab in China, Pronto Diagnostics in Israel, Ybux in the Czech Republic, Albiogen in Russia, Isogen Life Science in Benelux and Spain, and Camlab in the UK.
Terms of the deal were not disclosed.